Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) EBIT: 2019-2025

Historic EBIT for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$41.8 million.

  • Benitec Biopharma's EBIT fell 77.25% to -$9.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$41.8 million, marking a year-over-year decrease of 85.70%. This contributed to the annual value of -$41.8 million for FY2025, which is 85.70% down from last year.
  • Benitec Biopharma's EBIT amounted to -$41.8 million in FY2025, which was down 85.70% from -$22.5 million recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's EBIT registered a high of -$13.6 million during FY2021, and its lowest value of -$41.8 million during FY2025.
  • Moreover, its 3-year median value for EBIT was -$22.5 million (2024), whereas its average is -$27.8 million.
  • Data for Benitec Biopharma's EBIT shows a maximum YoY tumbled of 85.70% (in 2025) over the last 5 years.
  • Benitec Biopharma's EBIT (Yearly) stood at -$13.6 million in 2021, then slumped by 31.32% to -$17.9 million in 2022, then fell by 6.87% to -$19.1 million in 2023, then declined by 17.87% to -$22.5 million in 2024, then tumbled by 85.70% to -$41.8 million in 2025.